
Quarterly ResultAug 10, 2026, 07:37 AM
Surgery Partners Q2 Revenue $848.9M, Adj. EBITDA $125.2M
AI Summary
Surgery Partners, Inc. announced its second quarter 2026 results, reporting a 2.7% increase in revenue to $848.9 million and a 5.0% rise in same-facility revenues. The company posted a net loss of $15.0 million and Adjusted EBITDA of $125.2 million for the quarter. Management reaffirmed its full-year 2026 revenue guidance of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million, excluding the impact of a recently disclosed pending divestiture of its Idaho Falls facilities, which is part of its portfolio optimization strategy.
Key Highlights
- Revenue increased 2.7% to $848.9 million for the second quarter of 2026.
- Same-facility revenues grew 5.0% for the second quarter of 2026.
- Net loss attributable to Surgery Partners, Inc. was $15.0 million for Q2 2026.
- Adjusted EBITDA was $125.2 million for the second quarter of 2026.
- Reaffirmed full-year 2026 revenue guidance of $3.35 billion to $3.45 billion.
- Reaffirmed full-year 2026 Adjusted EBITDA guidance of at least $530 million.
- Announced pending divestiture of Idaho Falls facilities for portfolio optimization.
- Cash and cash equivalents were $216.7 million as of June 30, 2026.
Price Impact
More from SGRY